(March 19, 2024, 8:53 AM EDT) -- TRENTON, N.J. — In a lawsuit brought by a pharmaceutical supplier alleging that a pharmaceutical manufacturer breached a contract for the purchase of large quantities of hydroxychloroquine and chloroquine phosphate for the treatment and prevention of COVID-19, the manufacturer notified a New Jersey federal court that court-ordered mediation had concluded with the parties at an impasse....